Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Powerful Evaporator for Drug Discovery

Published: Thursday, December 19, 2013
Last Updated: Wednesday, December 18, 2013
Bookmark and Share
HT-4X centrifugal evaporator combines ease of use, compactness and operational versatility.

The HT-4X centrifugal evaporator from Genevac provides optimized sample preparation capabilities for scientists working in the drug discovery environment.

Built to the highest specifications, the HT-4X makes demanding applications routine. Corrosive vapours such as trifluoroacetic acid may be removed by the standard system and an inert purge option allows high safety evaporation of flammable solvents.

In addition, the HT-4X can also be used to achieve high speed lyophilization of HPLC fractions and solvents used for reformatting samples.

The HT-4X is a high performance evaporator that combines ease of use, compactness, operational versatility and efficient sample processing.

An innovative built-in dual chamber refrigerated condenser, that combines a powerful cryopump and solvent recovery system, together with extra powerful IR lamps, accelerates the speed of evaporation, even for high boiling point solvents such as DMSO.

In addition, efficient chamber cooling between runs is particularly useful to protect thermally sensitive samples when run immediately after higher boiling point solvents. The system additionally offers an auto-defrosting condenser option and novel functions such as auto shutdown and auto-solvent selection, making it extremely easy to use. Genevac’s patented SampleGuard™ and Dri-Pure® technology is included to protect samples from overheating and bumping.

Operated via an integral full colour screen the Genevac HT-4X offers comprehensive display of real-time data enabling rapid methods development across a wide range of applications.

The easy-to-use system provides facility to store up to 99 evaporation methods making it ideal for multi-user environments.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genevac Consolidate Evaporator & Freeze Dryer Sales Channels in the UK
Company appoints BioPharma Process Systems as exclusive UK distributor.
Thursday, May 15, 2014
GenVec Announces Manufacturing Agreement for TNFerade™
The agreement will cover technology transfer, scale-up, and validation of the manufacturing process for TNFerade through cGMP consistency lots.
Friday, January 25, 2008
Genevac Launches new Information-rich Website
According to Genevac its new website is an information hub for evaporation, concentration and lyophilization.
Tuesday, November 27, 2007
Genevac Ltd. Acquired by Riverlake Partners
The acquisition of Genevac from Thermo Scientific will play a critical role in Riverlake's SP Industries for future growth and expansion.
Friday, April 13, 2007
New Approach to Compound Library Maintenance
The report describes a new high throughput process to produce compound libraries as dry films that have been validated for long-term storage.
Thursday, April 06, 2006
Genevac Moves on WEEE Compliance
As a result of upgrade and trade-in schemes over the last year, Genevac took back and has recycled 150 evaporators.
Tuesday, March 21, 2006
High-throughput Evaporation of Strongly Acidic Chemicals
The new version of the HT-12 Series II system has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples.
Thursday, July 14, 2005
Genevac DD- 4 & Metz Syn10 on Display at Labautomation 2002

Monday, January 14, 2002
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos